Related Experiment Video
Updated: May 12, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
FA1 Induces Pro-Inflammatory and Anti-Adipogenic Pathways/Markers in Human Myotubes Established from Lean, Obese, and
Basem M Abdallah1, Henning Beck-Nielsen, Michael Gaster
1Molecular Endocrinology Laboratory (KMEB), Odense University Hospital, University of Southern Denmark Odense, Denmark.
Aims:
Delta like 1/fetal antigen 1 (Dlk1/FA1) is a protein secreted by hormone producing cells in adult human and mice that is known to inhibit adipogenesis. Recent studies demonstrated the role of Dlk1/FA1 in inducing insulin resistance in mice. To investigate the involvement of circulating Dlk1/FA1 in insulin resistance and type 2 diabetes in human subjects, we studied the effects of chronic FA1 on the intermediary metabolism in myotubes established from lean, obese, and type 2 diabetic (T2D) subjects.
Methods:
Myotube cultures were established from lean and obese control subjects, and obese T2D subjects and treated with soluble FA1 for 4 days supplemented with/without palmitate (PA). Lipid- and glucose metabolism were studied with labeled precursors while quantitative expression of genes was analyzed using real-time PCR.
Results:
Diabetic myotubes express significantly reduced insulin stimulated glucose metabolism compared to lean myotubes and a significantly decreased basal PA oxidation. Chronic FA1 exposure did not affect the intermediary metabolism in myotubes. Insulin sensitivity of glucose and lipid metabolism was not affected by chronic FA1 exposure in myotubes established from lean, obese, and T2D subjects. Instead, chronic FA1 exposure induced pro-inflammatory cytokines expression (IL-6 and CCL2) in association with reducing adipogenic markers (ADD1, AP2, CD36, and PPARg2) in myotubes. Consistent with this observation, addition of FA1 to cultured myotubes was show to significantly inhibit their differentiation into adipocyte.
Conclusion:
Our results exclude direct effects of FA1 on glucose and lipid metabolism in cultured myotubes established from lean, obese, and T2D subjects. Therefore, the pathogenesis of FA1-induced IR might mainly be mediated via the FA1-induced stimulation of pro-inflammatory cytokines, which on turn inhibit adipogenesis in human myotubes.
Insights
Delta like 1/fetal antigen 1 (Dlk1/FA1) does not directly impact glucose or lipid metabolism in human myotubes. Instead, FA1 promotes inflammation and inhibits adipogenesis, potentially contributing to insulin resistance.
Area of Science:
- Endocrinology
- Metabolic research
- Cell biology
Background:
- Delta like 1/fetal antigen 1 (Dlk1/FA1) is a secreted protein known to inhibit adipogenesis.
- Previous studies suggest Dlk1/FA1 induces insulin resistance in mice.
- The role of circulating Dlk1/FA1 in human insulin resistance and type 2 diabetes requires further investigation.
Purpose of the Study:
- To investigate the involvement of circulating Dlk1/FA1 in insulin resistance and type 2 diabetes in human subjects.
- To study the effects of chronic FA1 on intermediary metabolism in human myotubes from lean, obese, and type 2 diabetic individuals.
Main Methods:
- Myotube cultures were established from lean, obese, and type 2 diabetic (T2D) subjects.
- Cultures were treated with soluble FA1 with or without palmitate (PA).
- Glucose and lipid metabolism were assessed using labeled precursors; gene expression was analyzed via real-time PCR.
Main Results:
- Diabetic myotubes showed reduced insulin-stimulated glucose metabolism and basal PA oxidation compared to lean myotubes.
- Chronic FA1 exposure did not directly affect intermediary metabolism in any group.
- FA1 induced pro-inflammatory cytokines (IL-6, CCL2) and reduced adipogenic markers, inhibiting myotube differentiation into adipocytes.
Conclusions:
- FA1 does not directly impact glucose and lipid metabolism in human myotubes.
- FA1-induced insulin resistance may be primarily mediated by pro-inflammatory cytokine stimulation, which subsequently inhibits adipogenesis.
More Related Videos
Related Concept Videos
Type II Diabetes II: Pathophysiology
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Type I Diabetes II: Pathophysiology
Obesity

